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Abstract.  Rapid downregulation of L-selectin expres- 
sion occurs in response to leukocyte activation, and it 
has been speculated to be an integral process in the 
adhesion cascade leading to neutrophil recruitment to 
sites of inflammation. It has previously been proposed 
that L-selectin is proteolytically cleaved from the cell 
surface; however, the nature of the cleavage site has 
been unknown. We have produced polyclonal antisera 
against the extracellular domain and against the cyto- 
plasmic domain of L-selectin. Both antisera immuno- 
precipitate the intact form of L-selectin from meta- 
bolically labeled phytohemagglutinin-stimulated 
lymphoblasts and peripheral blood neutrophils. In addi- 
tion, the anti-cytoplasmic domain serum, but not the 
antiectodomain serum, immunoprecipitate a 6-kD spe- 
cies from PMA activated lymphoblasts and formyl- 
methionylleucylphenylalanine-activated  neutrophils. 
Conversely, the antiectodomain serum but not the 
anti-cytoplasmic domain serum immunoprecipitate a 
68-kD soluble form of L-selectin from the supernatant 
of PMA-activated lymphoblasts. The appearance of the 
6-kD species on activated cells correlated with the dis- 
appearance of the intact form of L-selectin and the ap- 
pearance of the soluble form of L-selectin. A  third 
polyclonal serum generated against the membrane 
proximal region of the ectodomain also reacted with 
the 6-kD species, indicating that this is a transmem- 
brane peptide of L-selectin. That the 6-kD species is 
derived from L-selectin was confirmed by immunopre- 
cipitation of the 6-kD species from L-selectin transfec- 
tants but not from mock transfectants. Radiochemical 
sequence analysis defined a cleavage site between 
Lys  TM  and Ser  322, which would predict a transmem- 
brane fragment consistent in size with the observed 
6-kD fragment. A  Ser-Phe-Ser motif adjacent to the 
cleavage site is conserved between human, mouse, and 
rat L-selectin, and a related motif is found proximal 
to transmembrane domains of other downregulated 
proteins, such as ACE, CD16-II, and TNF-RII,  sug- 
gesting the possibility of a common recognition motif. 
EUKOCYTE localization to sites of inflammation is a pre- 
cisely coordinated multistep  process involving dis- 
tinct families of adhesion receptors and chemokines 
(9, 56). Regulation of the neutrophil adhesive state is critical 
for leukocyte function. One major neutrophil adhesion mol- 
ecule, the Mac-1/3~ integrin (CDIlb/CD18), is both quan- 
titatively upregulated (59) and assumes an active conforma- 
tion upon neutrophil  exposure to chemotactic factors (10). 
In contrast, another major neutrophil  adhesion  molecule, 
L-selectin, is rapidly downregulated upon neutrophil activa- 
tion (5,  17, 26, 28, 29).  However, antibodies against either 
Mac-1  or  L-selectin are  effective in  blocking  neutrophil 
recruitment to sites of inflammation in vivo (28, 36, 62) and 
neutrophil  adhesion to stimulated endothelial cells in vitro 
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(18, 20, 31, 51, 52, 54). The observation that L-selectin and 
Mac-1 are inversely regulated upon activation provided the 
theoretical  basis for a model of neutrophil-endothelial  cell 
interaction (29),  where L-selectin is involved in the early 
adhesion  events,  while  Mac-1  is  required  for  adhesion 
strengthening and transendothelial migration (1, 37, 51, 60). 
The precise regulation and the rapid kinetics of L-selectin 
downregulation is suggestive of a role in the progression of 
neutrophil  emigration. 
Normal lymphocyte traffic to peripheral lymph nodes is 
also mediated by L-selectin.  L-selectin is downregulated on 
activated lymphocytes, although with a slower time course 
than that of neutrophils  (19, 24,  25, 30).  Previous  studies 
have shown that a large fragment of L-selectin corresponding 
to the expected size of the extracellular portion of L-selectin 
can be recovered from the supernatant of activated neutro- 
phils (5, 29) and lymphoid cells  (24).  A  soluble  form of 
L-selectin is found at high concentrations (1.5-2.0 #g/ml) in 
normal human serum (47), in culture supernatants  of lym- 
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and  L-selectin-transfected  embryonic  kidney  ceils  (34). 
Based on the rapid kinetics of L-selectin downregulation, it 
has been postulated that L-selectin is cleaved by an activated 
membrane protease (5, 24, 29). However, the mechanism of 
L-selectin downregulation has remained unclear, since pro- 
tease inhibitors have no effect on L-selectin shedding in re- 
sponse to neutrophil activation (references 12, 27, 48 and un- 
published observations). 
Recently, the concept of membrane proximal cleavage of 
transmembrane proteins has emerged as a specific and in- 
ducible mechanism to rapidly modulate cell surface expres- 
sion  of diverse  proteins  (15). Many  growth  factors  and 
cytokines, such as TGF-o~ (42), colony-stimulating factor-1 
(CSF-1) (57),  and Kit ligand (22),  have a  transmembrane 
bound form that can be specifically released from the cell 
surface by a  proteolytic mechanism upon cell activation. 
Similarly, cell surface receptors and ectoenzymes, such as 
the TNF receptor (32, 44), folate receptor (16), ~amyloid 
protein (41, 63), and angiotensin-converting enzyme (ACE) 
(14) can be cleaved to release a soluble form. It is unknown 
whether  the  mechanism  for  rapid  downmodulation  of 
L-selectin is related to modulation of these other critical cell 
surface proteins. 
If the ectodomain of L-selectin is released from the cell 
surface by specific proteolytic cleavage,  then a transmem- 
brane peptide fragment of L-selectin should be recoverable 
from activated leukocytes. In this report, we have raised a 
polyclonal antiserum against a synthetic peptide correspond- 
ing to the cytoplasmic domain of  L-selectin. We demonstrate 
that this antiserum can recognize the intact form of L-selec- 
tin, as well as a 6-kD transmembrane fragment of L-selectin 
associated with activated leukocytes and L-selectin transfec- 
tants. We further identified the cleavage site by radiochemi- 
cal  sequence analysis of the 6-kD  species.  These results 
confirm membrane-proximal cleavage as the mechanism for 
rapid downregulation of L-selectin. 
Materials and Methods 
Polyclonal  Antisera 
A  polyclonal  antiserum  against  the  extraceilular  domain  of L-selectin 
(JK923) was generated by hyperimmunization of a rabbit with a purified 
preparation of a soluble, truncated form of L-selectin. An L-selectin eDNA 
lacking the coding sequence for the transmembrane and cytoplasmic do- 
mains was generated by PCR and subeloned into the CDM8 vector. COS 
cells were transfected with this construct by DEAE-dextran as previously 
described (11). Supernatants from transfected cells were harvested on days 
3-14 after transfection, and soluble L-selectin was purified on a DREG-200 
anti-L-selectin mAb column (30). 
A  polyclonal antiserum against the cytoplasmic domain of L-selectin 
(JK564)  was generated by hyperimmunization of a  rabbit with a  BSA- 
conjugated lgmer synthetic peptide corresponding to the entire cytoplasmic 
domain of L-selectin with an additional NH2-terminal  cysteine residue 
(NH2-CRRLKKGKKSKRSMNDPY-COOH).  The  peptide  was  reduced 
and coupled via the sulfbydryl group of the NH2-terminal cysteine residue 
to maleimide-activated BSA (Pierce Chemical Co., Rockford, IL), accord- 
ing to the manufacturer's instructions. The NH2-terminal linkage provides 
an orientation similar to that expected of the cytoplasmic domain extending 
from the membrane bilayer. 
I. Abbreviations  used in this paper: ACE, angiotensin-converting enzyme; 
CSF-1; colony-stimulating factor-l; fMLP, formylmethionylleucylphenylal- 
anine; L-STMP, L-selectin transmembrane peptide; PHA, phytohemagglu- 
tinin; PVDE polyvinylidenefluoride; SCR, short consensus repeat. 
A polyclonai antiserum against the membrane proximal region of the ex- 
tracellular domain (JK924) was generated by hyperimmunization of a rabbit 
with a keyhole limpet hemacyanin-conjugated 18mer synthetic peptide cor- 
responding to the membrane-proximal region with an additional COOH- 
terminal cysteine residue (NH2-QKLDKSFSMIKEGDYNPC-COOH). The 
peptide was reduced and coupled to maleimide-activated keyhole limpet 
hernacyanin as described above.  The COOH-terwinal linkage provides an 
orientation similar to that expected of the ectodomain extending from the 
membrane bilayer. 
Monoclonal Antibodies 
The monoclonal antibody DREG-56 against the extracellular domain of 
L-selectin was prepared as previously described (30). CA21 hybridoma cell 
lines producing mAb directed against the cytoplasmic domain of L-selectin 
were prepared by hyperimmunization of BALB/c mice with a synthetic pep- 
tide corresponding to the entire cytoplasmic domain of L-selectin, as de- 
scribed above. Spleen cells were fused with the SP2/0 myeloma fusion part- 
ner, as described previously (30). Hybridoma supernatants were screened 
for the ability to specifically recognize immobilized cytoplasmic domain 
peptide. Positive clones were further screened for the ability to immunopre- 
cipitate L-selectin. CA21  (IgG1) mAb was purified by protein G affinity 
chromatography. 
Metabolic Labeling 
COS cells were transiently transfected with eDNA encoding L-selectin (or 
mock transfected) by the DEAE-dextran method, as described previously 
(11). 3 d later, cells were metabolically labeled with [35S]methionine  (New 
England Nuclear,  Boston, MA). The COS monolayers were first prein- 
cubated in methionine-free RPMI 1640 containing 10% dialyzed FCS for 
20 win at 37°C to deplete intracellular pools of methionine. Cells were 
pulse labeled with [35S]methionine  (0.5-1.0  mCi/100-mm dish) for various 
times, as indicated. The COS cells were then chased with complete RPMI 
1640.  Culture supematants were harvested and centrifuged to remove any 
nonadherent ceils or debris. Monolayers were lysed for 30 win at 4°C in 
1 ml of 1% Triton X-100 in 10 mM Tris (pH 8)-saline-0.025% azide con- 
taining 1% ovalbuwin, 1 mM aprotinin, and 1 mM freshly added PMSF 
(lysis buffer). Cell nuclei were pelleted by centrifugation at 12,000 g. 
Human mononuclear and PMN leukocytes were isolated from peripheral 
blood by Ficoll-Hypaque centrifugation and dextran sedimentation, as de- 
scribed previously (51).  PHA-stimulated lymphoblasts were generated by 
incubating the mononuclear leukocytes with 2.5/~g/ml PHA (Sigma Im- 
munochewicals, St. Louis, MO) in complete RPMI 1640 medium for 5 d 
at 37°C. The PHA lymphoblasts were harvested on day 5 and metabolically 
labeled with [3SS]methionine  as described above. Freshly isolated human 
PMN were metabolically labeled as described (38). Briefly, PMN were la- 
beled at  2  ×  107  cells/ml for 5  h  at  37°C.  PMA (100  ng/ml) or  for- 
mylmethionylleucylphenylalanine (10  -6 M) was added in the final 30 min 
as indicated. 
Immunoprecipitation and SDS-PAGE 
Cell lysates were precleared with normal rabbit serum followed by protein 
A-agarose. Preimmune serum or specific serum was added to aliquots of 
the precleared lysates and cell-free supernatants. The samples were in- 
cubated at 4°C for 1-2 h and then 15/xl of a protein A-agarose slurry was 
added to each sample. Samples were rotated end-over-end  at 4°C for 30 win 
and then washed extensively. The specifically bound material was elnted by 
addition of SDS-PAGE sample buffer followed by incubation at 90°C for 
10  min.  Eluates  were resolved on tricine-SDS polyacrylamide gradient 
(10-20 %) gels (NOVEX, Encinitas, CA). Gels were subjected to fluorogra- 
phy (Enhance; New England Nuclear) and autoradiography. 
Western Blot Analysis 
An activated human granulocyte lysate was passed over a CA21 anti-cyto- 
plasmic domain mAb column.  The column was washed extensively and 
eluted  with  50  mM  glycine  (pH  2)  solution  containing  1%  octyl 
thioglucopyranoside. Fractions were neutralized with Tris buffer and ana- 
lyzed by dot blot analysis. Aliquots of partially purified material were sub- 
jected to SDS-PAGE on 10-20% polyacrylamide-SDS-tricine  gels. Samples 
were transferred to polyvinylidenefluoride (PVDF) membrane (Immobilon 
pSQ; Millipore  Corp.,  Bedford,  MA)  in  10  mM  CAPS  (3-cyeiohexyl- 
amino-l-propanesulfonic acid) buffer (pH  11) containing 10%  methanol. 
The membrane was blocked with 2 % BSA, and the transferred material was 
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phosphatase-conjugated secondary antibody (Promega Corp.,  Madison, 
WI)  followed  by  5-bromo-4-chloro-3-indolyl phosphate  and  nitroblue 
tetrazolinm chloride, as described previously  (30). 
Radiochemical Sequence Analysis 
COS cells transfected with human L-selectin eDNA were metabolically la- 
beled  with  [3~S]methiouine  (specific  activity  >1,000  Ci/mmol;  0.5 
mCi/100-mm dish), as described above. COS cell transfectants were also 
metabolically labeled with [3H]phenylalanine (specific activity =  100-130 
Ci/mmol), as described above with the following modifications:  the cells 
were pulse labeled for 5 h in phenylalanine-free  RPMI 1640 and then simul- 
taneously chased and activated by the addition of excess  nonradioactive 
phenylalanine and PMA (100 ng/ml) for 30 rain. The cells were lysed and 
treated as described above.  PHA-stimulated  lymphoblasts (5  x  106-1 × 
10711111)  were  metabolically  labeled  with  either  [35S]methionine  or 
[3H]phenylalanine  for 4-5  h,  as described above.  The cells were then 
simultaneously chased with the appropriate nonradioactive amino acid and 
activated with PMA (I00 ng/ml) for 30 win. The 6-kD species was immuno- 
precipitated as described above.  The material was resolved on a tricine 
SDS-polyacrylamide  (10-20%)  gradient  gel  (NOVEX)  and  then  elec- 
trotransferred in Tris-glycine  buffer to a  PVDF membrane (Immobilon 
psQ; MiUipore Corp.). The membrane was air dried and exposed to Kodak 
X-OMAT AR film. The film was subsequently developed,  aligned with the 
Immobllon membrane, and the area of the membrane corresponding to the 
point of migration of the 6-kD species was excised  and subjected to se- 
quencing on a pulse-liquid protein sequencer (model 477A; Applied Bio- 
systems, Inc., Foster City, CA). Fractions were collected from each Edman 
degradation cycle and analyzed in a liquid scintillation counter (Beckman 
Instruments, Inc., Fullerton, CA). 
Results 
Identification of a 6-kD Species on PHA Lymphoblasts 
We  initially  raised  two  antisera  against  L-selectin,  one 
directed against purified soluble L-selectin, which lacked the 
transmembrane and cytoplasmic domains (antiectodomain 
serum JK923), and another directed against a synthetic pep- 
tide  corresponding  to  the  entire  cytoplasmic  domain  of 
L-selectin  (anti-cytoplasmic  domain  serum JK564).  The 
antiectodomain  serum  specifically  stained  intact,  unacti- 
vated leukocytes,  while the anti-cytoplasmic  domain  serum 
stained only permeabilized cells (data not shown). Both an- 
tisera  immunoprecipitated  the  intact  membrane-spanning 
form of L-selectin (Fig.  1 A and data not shown). 
The ability of these antisera to detect processed fragments 
of L-selectin on activated  leukocytes was examined.  The 
primary  sequence  of L-selectin  predicts  six  methionine 
residues, two of which are located in the cytoplasmic and 
transmembrane domains.  A third methionine  residue is lo- 
cated in the ectodomain, 10 amino acids proximal to the be- 
ginning  of the transmembrane domain. Therefore,  we rea- 
soned that both a transmembrane fragment of L-selectin, as 
well as a soluble form of L-selectin, should be detectable 
from activated cells metabolically labeled with psS]methio- 
nine.  Lympboblasts stimulated  with PHA for 5 d actively 
synthesized  L-selectin.  The anti-ectedomain serum immu- 
noprecipitated the intact 74-kD L-selectin molecule from 
biosynthetically labeled cells  (Fig.  1 A).  Although  PHA 
blasts are actively proliferating  and constitutively  produce a 
soluble form of L-selectin (55), addition of pborbol esters 
(PMA) provided a further activating  signal  that  induced a 
significant  increase in the downregulation  of newly synthe- 
sized cell surface L-selectin.  This is evidenced by reduced 
levels of intact L-selectin in immunoprecipitates from cell 
lysates (Fig.  1 B), increased levels of soluble L-selectin in 
immunoprecipitates  from cell-free supernatants  (Fig.  1 C), 
and decreased cell surface expression of L-selectin (data not 
shown).  The  anti-cytoplasmic domain  serum also recog- 
nized the intact form of L-selectin (Fig. 1, A and B), but not 
the soluble form (Fig.  1 D). These results indicated that the 
classical transmembrane form of L-selectin is the major spe- 
cies  found  on  these  cells,  and  that  the  soluble  form  of 
L-selectin lacks the cytoplasmic tail.  In addition,  a  faint 
band  of 6  kD  could  be  reproducibly  detected  with  the 
anti-cytoplasmic domain serum in cell lysates of day 5 PHA 
blasts (Fig.  1, A and B). Activation  of lymphoblasts with 
PMA caused a marked decrease in the amount of detectable 
74-kD  intact  L-selectin and  a  concomitantly marked  in- 
crease in the amount of the 6-kD species (Fig. 1 B). Addition 
of the microfilament disrupting  agent cytochalasin B did not 
inhibit or enhance the downregulation  of intact L-selectin or 
the appearance of the 6-kD species (Fig.  1 B). These data 
suggested that the 74-kD intact L-selectin species is cleaved 
upon activation with PMA to yield a 6-kD cell bound frag- 
ment and a 68-kD soluble fragment,  and that this cleavage 
does not require cytoskeletal involvement. 
A 6-kD Species is Associated with PMA- and 
fM~tivated  Neutrophils 
Neutrophils  also  rapidly  downregulate  L-selectin  in  re- 
sponse to activation  by chemotactic factors or phorbol es- 
ters. Although neutrophils are a terminally differentiated cell 
type with few ribosomes and limited endoplasmic reticulum, 
others have shown that neutrophil proteins can be metaboli- 
cally labeled (38). Since L-selectin mRNA has been isolated 
from peripheral blood neutrophils  (39), we next examined if 
L-selectin biosynthesis could be detected. An intact form 
of L-selectin was immunoprecipitated with both the anti- 
ectodomain serum and the anti-cytoplasmic domain serum 
from  neutrophils  metabolically labeled with  [35S]methio- 
nine (Fig. 2). As reported previously (17, 36), the neutrophil 
form of L-selectin migrated more slowly than the lympho- 
cyte form by SDS-PAGE, presumably because of additional 
posttranslational  modifications  (39).  Activation of the neu- 
trophils with either fMLP chemoattractant or phorbol esters 
resulted in greatly reduced amounts of intact L-selectin, with 
a corresponding increase in a 6-kD species immunoprecipi- 
tated with the anti-cytoplasmic domain serum (Fig. 2). This 
result was somewhat unexpected, since prolonged culture of 
neutrophils necessary for metabolic labeling can induce neu- 
trophil  shape  change  and degranulation,  and might  be ex- 
pected to result in immediate  L-selectin downregulation. 
However, these results suggested that downregulation  of the 
newly  synthesized  L-selectin  is  greatly  enhanced  by  a 
specific  activating  agent.  Since  these  cultures  were  not 
chased with cold methionine,  a precursor form of L-selectin 
(L', Fig. 2) was evident in these immunoprecipitations.  The 
L-selectin precursor was not downregulated  in response to 
PMA or fMLP (Fig. 2), suggesting that only the mature cell 
surface form of L-selectin is susceptible to cleavage. The es- 
timated size of the 6-kD species is consistent with our previ- 
ous observation that I~I surface labeled L-selectin released 
into the supernatant  is ,~4 kD smaller than the membrane- 
bound form (29). 
The 6-kD Species is a Specific Product of  L-Seiectin 
To  confirm  that  the  6-kD  species  is  directly  related  to 
Kahn et al. Membrane Proximal Cleavage of L-Selectin  463 Figure .I. Identification  of a 6-kD species in metabolically labeled  PHA lymphoblasts.  Peripheral  blood lymphocytes were stimulated  with 
PHA for 5 d. Lymphoblasts were pulse labeled  with [35S]methionine for 15 rain and chased with cold methionine for 30 rain.  Cells were 
treated with PMA (100 ng/ml) or cytochalasin B for 30 min, as indicated.  (A and B) Labeled cells were lysed in 1% Triton X-100 solution, 
and cell lysates were immunoprecipitated with antiserum directed against the ectodomain of L-selectin (JK923),  the cytoplasmic domain 
of L-selectin (JK564),  or with preimmune serum, as indicated.  Upper arrow, the position of the intact form of L-selectin; lower arrow, 
the position of  the putative 6-kD transmembrane cleavage product. The 42-kD band observed in all lanes, including the preimmune control, 
of  A is likely to be actin, and it is more prominent in this figure because the gel was intentionally  overexposed to bring out the 6-kD band. 
(C and D) Cell-free  supernatants  were immunoprecipitated with antisera  against the ectodomain or the cytoplasmic domain of L-selectin 
or with preimmune serum, as indicated.  Arrow, the position of the soluble form of L-selectin. Immunoprecipitates were subjected to SDS- 
PAGE on 10-20% gradient gels and visualized  by autoradiography with fluorography. 
L-selectin,  we compared COS  cells  that  were  transfected 
with L-selectin cDNA vs those that were mock transfected. 
Lasky et al. (34) have previously shown that L-selectin trans- 
fectants produce a soluble form of L-selectin. We confirmed 
this  observation  and  extended  it  to  demonstrate  that  the 
anti-cytoplasmic  domain  serum  immunoprecipitated  both 
the intact L-selectin and the 6-kD species  from L-selectin 
transfectants,  but not mock transfectants (Fig.  3 A). More- 
over, the anti-cytoplasmic domain serum did not react with 
the soluble  L-selectin from COS cell  supernatants  (Fig.  3 
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Peripheral  blood  neutrophils  were  metabolically  labeled  with 
[35S]methionine for 5  h  without  chase,  as  described  previously 
(38). Cells were treated with fMLP or PMA in the last 30 min of 
the labeling period, as indicated. Cell lysates were immunoprecipi- 
tated  with  antisera  against the cytoplasmic  domain,  the  ectodo- 
main, or with preimmune serum, as indicated. Immunoprecipitates 
were analyzed as described in Fig.  1. L ~  denotes the position of 
the  mature cell  surface  form of the neutrophil  L-selectin. U "* 
denotes the position of the biosynthetic precursor form of L-selec- 
tin. Lower arrow, the position of the putative 6-kD cleavage prod- 
uct. Note that the neutrophil form of L-selectin migrates slower than 
the lymphocyte form of L-selectin because of differences in post- 
translational  modifications,  as previously described  (20, 40, 45). 
Immunoprecipitates were subjected to SDS-PAGE on 10-20% gra- 
dient gels and visualized by autoradiography  with fluorography. 
B).  These results strongly indicate that the 6-kD species is 
a specific product of L-selectin and that COS cells can con- 
stitutively process L-selectin in a manner similar to that of 
activated leukocytes. 
Western Blot Analysis of the 6-kD Species 
During the course of these experiments, a  series of mouse 
mAb,  CA21,  directed  against  the  cytoplasmic domain  of 
L-selectin was developed. The CA21  mAb, like the JK564 
polyclonal anti-cytoplasmic domain serum, immunoprecip- 
itated  the  6-kD  species  from lysates  of L-selectin-trans- 
fected COS cells (Fig. 4 A). 
It was possible that the 6-kD species coprecipitated with 
L-selectin  and  was  not  directly  related  to  a  fragment of 
L-selectin.  This seemed unlikely, given the correlation be- 
tween the appearance of the 6-kD species and the disappear- 
ance of the intact L-selectin on activated leukocytes. How- 
ever, to formally exclude this possibility, lysates of activated 
neutrophils were subjected to affinity chromatography fol- 
lowed by Western  blot  analysis.  The  CA21  mAb reacted 
directly with both the intact form of L-selectin and the 6-kD 
species by Western blot analysis (Fig. 4  B).  Control mAb 
showed  no  reactivity  under  these  conditions  (data  not 
shown).  These  results  indicated  that  the  6-kD  species  is 
related to the cytoplasmic domain of L-selectin,  and they 
also confirmed that  activated neutrophils  can produce the 
6-kD species. 
The 6-kD L-Selectin Product is a 
Transmembrane Peptide 
A 6-kD COOH-terminal fragment of L-selectin would indi- 
cate a transmembrane peptide of ',~50-55 amino acids. This 
would map the putative cleavage site to a short region of the 
ectodomain,  between  the  COOH  terminus  of the  second 
short consensus repeat (SCR) and the beginning of the trans- 
membrane domain (Fig.  5  A).  Interestingly, this region is 
well conserved between mouse (34, 49), rat (61), and human 
L-selectin (8,  11, 50, 58), but is not conserved between L-, 
E-, and P-selectin (6, 23) (Fig. 5 A). Although soluble forms 
of E-selectin  and  P-selectin  have been described,  neither 
protein is regulated in the same manner as L-selectin.  To 
confirm that the 6-kD species is a transmembrane product 
of L-selectin, we produced a third polyclonal serum (JK924) 
against  a  synthetic  peptide  (NHe-QKLDKSFSMIKEGDY- 
NPC-COOH) corresponding to the sequence of this putative 
membrane-proximal  cleavage  domain  with  an  additional 
COOH-terminal cysteine residue, as described in Materials 
and Methods. Both the JK924 anti-cleavage domain serum 
and the JK564 anti-cytoplasmic domain serum immunopre- 
cipitated the  6-kD  species  from cell  lysates of L-selectin 
transfectants  (Fig.  5  B).  In  some  experiments  using  the 
Figure  3.  The  6-kD  species  is  a  fragment of 
L-sdectin. COS cells were transiently transfected 
with a cDNA clone encoding the membrane form 
of L-selectin  or were mock transfected,  as indi- 
cated.  On day  3  of posttransfection,  cells  were 
pulse-labeled  with  [3SS]methionine for  60  min 
and chased for 120 min. (A) Cell lysates were im- 
munoprecipitated  with  antisera  directed  against 
the cytoplasmic domain of L-selectin, the ectodo- 
main of L-selectin, or with preimmune serum, as 
indicated.  Upper arrow, the position of the intact 
form of  L-selectin; lower arrow, the position of  the 
putative  transmembrane  cleavage  product.  (B) 
Cell-free supematants  of labeled COS cells were 
immunoprecipitated with polyclonal antiserum or 
the DREG-56 mAb, as indicated. Arrow, the posi- 
tion  of  the  soluble  form  of  L-selectin.  Lm- 
munoprecipitates were subjected to SDS-PAGE  on 
10-20% gradient gels and visualized by autoradi- 
ography with fluorography. 
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domain detects the 6-kD species. (,4) COS cells were transfected 
with full-length L-selectin eDNA and labeled with  [35S]methio- 
nine, as described in the Fig. 3 legend. Cell lysates were immuno- 
precipitated  with  JK564  anti-cytoplasmic  domain  serum,  the 
CA21 series of mAb (C2k21-2E12, CA21-4F8, CA21-4DI0, CA21- 
3F3), or irrelevant control mAb, as indicated, lmmunoprecipitates 
were subjected to SDS-PAGE and autoradiography. The figure was 
truncated to show only the relevant area of  the gel. Arrow, the posi- 
tion of the 6-kD putative cleavage product of L-selectin. (B) Ly- 
sates of activated neutrophils were partially purified on a CA21- 
2E12 anti-L-selectin  cytoplasmic domain mAb affinity column, 
subjected to  SDS-PAGE and  transferred  to  an  Immobilon  psQ 
membrane. The membrane was blocked in 1% BSA and probed 
with CA21-2EI2 mAb. Bands were visualized by addition of a sec- 
ond stage goat anti-mouse IgG-alkaline phosphatase conjugate fol- 
lowed by development with BCIP and NBT. Prestained molecular 
weight standards were used to monitor transfer efficiency. Upper 
arrow, the position of the intact neutrophil L-selectin; lower  arrow, 
the position of the 6-kD putative cleavage product of L-selectin. 
JK924 serum, an 18-kD band was found to be variably as- 
sociated with L-selecrin. This 18-kD band, unlike the 6-kD 
species, did not react directly with any of our antibodies by 
Western blot analysis (unpublished observation). Thus, the 
6-kD  species  reacted with  two independent antisera,  one 
directed  against  membrane-proximal  extracellular  deter- 
minants and the other directed against cytoplasmic domain 
determinants. These results indicated that the 6-kD species 
is a transmembrane peptide fragment of L-selecrin. 
Identification of the Cleavage Site 
To determine the actual cleavage site, the 6-kD species was 
purified  for  NH2-terminal  sequence  analysis.  Since  the 
deduced amino acid sequence of L-selectin is known (8,  11, 
50,  58), we performed radiochemical sequence analysis of 
the 6-kD species from L-selecrin-transfected COS cells bio- 
synthetically labeled with [35S]methionine.  The cell lysate 
was immunoprecipitated with the anti-cytoplasmic domain 
serum, subjected to SDS-PAGE, and transferred to PVDF 
membrane. The 6-kD band was visualized by autoradiogra- 
phy, excised, and subjected to protein sequencing. Radioac- 
tive peaks were observed at cycles 4 and 20 (Fig. 6 A), indi- 
caring methionine residues at these positions. A spacing of 
16 amino acids between the two methionine residues is found 
only between MeO  25 and Met  ~  of the L-selecrin sequence, 
suggesting that L-selectin was cleaved between Lys  321 and 
Ser  322.  No  radioactivity  was  observed  with  mock-trans- 
fected COS cells (data not shown). To confirm this predicted 
cleavage site, we performed radiochemical sequence analy- 
sis with COS transfectants biosynthetically labeled with an- 
other radiolabeled amino acid, [3H]phenylalanine. Radioac- 
tive peaks were observed at cycles 2, 14, and 24 (Fig. 6 B), 
indicating phenylaianine residues at these sites. The spacing 
between the observed peaks  was  consistent only with the 
spacing  between Phe  323, Phe  335, and  Phe  ~5  of L-selectin, 
again indicating a  cleavage site between Lys  TM  and Ser  322. 
Cleavage at this site would produce a transmembrane peptide 
with a predicted molecular mass of 5,823 D, which is in ex- 
cellent agreement with the observed relative molecular mass 
of 6,000 by SDS-PAGE.  To confirm that this is a  natural 
cleavage site, and not an artifact of the COS expression sys- 
tem,  we biosynthetically labeled PHA lymphoblasts with 
[35S]methionine  and  [3H]phenylalanine. Again,  radioactive 
peaks were observed at cycles 4  and 20 with psS]methio- 
nine (Fig. 6 C), and prominent peaks were observed at cycles 
2  and  14 with [3H]phenylalanine (data not shown).  These 
results confirm that L-selecrin is cleaved between Lys  32~ and 
Ser  322, and they indicate that COS cells process L-selectin 
in a  manner indistinguishable from that of PHA lympho- 
blasts. 
Discussion 
We have identified a 6-kD L-selectin transmembrane peptide 
(L-STMP) on activated leukocytes and on L-selectin trans- 
fectants. The 6-kD L-STMP reacted with monoclonal anti- 
bodies and polyclonal antiserum directed against the cyto- 
plasmic domain of L-selecrin, as well as with an antiserum 
directed against a  17-amino acid region of the ectodomain 
adjacent to the transmembrane domain. Appearance of the 
6-kD L-STMP on activated leukocytes correlated with the 
disappearance of the intact membrane-bound L-selectin and 
with the appearance of  a soluble form of L-selectin in culture 
supernatants. Previous studies have estimated that the solu- 
ble form of L-selectin is 4 kD (29) to 12 kD (24) smaller than 
the intact membrane form. However, the precise nature of 
L-selectin processing has been difficult to determine because 
the large,  heavily glycosylated ectodomain migrates  as  a 
diffuse  band  by  SDS-PAGE.  In  contrast,  the  L-STMP 
migrated as a sharp band with an apparent molecular mass 
of 6.0-6.5 kD. The size of the 6-kD form would indicate a 
putative cleavage site in a short region between the COOH 
The Journal of Cell Biology, Volume 125,  1994  466 Figure 5. The 6-kD species is an L-selectin transmembrane peptide (L-STMP). (A) Sequence of the putative membrane-proximal  cleavage 
region of  human L-selectin, based on the size estimate of  the 6-kD species, aligned with the corresponding regions of mouse and rat L-selec- 
tin, as well as human E-selectin and P-selectin. Conserved residues in this region are boxed, and the COOH terminus of the last SCR 
domain and the NH2 terminus of the transmembrane domain are indicated. (B) A rabbit antiserum (JK924) was raised against a synthetic 
peptide corresponding to the putative cleavage region as described in Materials and Methods. Lysates of L-selectin-transfected COS cells 
metabolically labeled with [3SS]methionlne  were immunoprecipitated with JK924 antisera against the putative cleavage region, JK564 
anti-cytoplasmic domain serum, CA21 anti-cytoplasmic domain mAb, or preimmune serum, as indicated. The figure was truncated to 
show only the relevant area of the gel. Arrow, the position of the 6-kD cleavage product of L-selectin. 
terminus of the second SCR and the beginning of the trans- 
membrane domain. This estimate is also consistent with rec- 
ognition of  the 6-kD species by an antiserum directed against 
a  synthetic peptide corresponding to this membrane prox- 
imal extracellular region. Radiochemical sequence analysis 
of the L-STMP molecule predicts a cleavage site between 
Lys  TM  and Set  322. Cleavage at this site would yield a trans- 
membrane  peptide  fragment with  a  predicted  molecular 
mass of 5,823 D, consistent with our observed size estimate. 
Although the extracellular domains of L-, E-, and P-selectin 
are well conserved (6, 8, 11, 23, 50, 58), this short membrane 
proximal region including the cleavage sequence is highly 
divergent. This is consistent with the observation that only 
L-selectin is rapidly downregulated in this manner. Taken to- 
gether, these results strongly support the model that L-selec- 
tin is cleaved at a membrane proximal site. 
It has previously not been possible to formally demon- 
strate a proteolytic mechanism involved in L-selectin down- 
regulation because of its lack of sensitivity to protease inhib- 
itors. Although the addition of exogenous chymotrypsin can 
selectively remove L-selectin from the ceil surface, a variety 
of chymotrypsin  inhibitors had no affect  on L-selectin down- 
regulation on activated cells (27). L-selectin dewnregulation 
has also been reported to be resistant to the serine protease 
inhibitors,  aprotinin,  or  PMSF  (12),  and  to  the  metal- 
loprotease inhibitor phosphoramidon (48).  Moreover,  we 
have expanded the search and have found that L-selectin 
downregulation is insensitive to a battery of inhibitors of 
serine proteases (PMSF, 4-amidinophenyl methyl sulfonyl 
fluoride, aprotinin, antipain, leupeptin, tosyl-L-lysine chio- 
romethyl ketone,  and  tosyl-L-pbenylalanine chloromethyl 
ketone), metalloproteases (EDTA, phosporamidon, leupep- 
tin, antipain, and bestatin), aspartic proteases (pepstatin), 
and thiol proteases (E64) (unpublished observations). How- 
ever, the identification  of  the 6-kD transmembrane fragment 
and the soluble extracellular fragment of L-selectin on neu- 
trophils and lymphocytes  clearly indicate that the transmem- 
brane form of L-selectin is  the dominant form,  and that 
downregulation occurs via a proteolytic mechanism. 
Membrane proximal cleavage has recently emerged as a 
specific mechanism to rapidly modulate cell surface expres- 
sion of a limited but diverse subset of transmembrane pro- 
teins. Other leukocyte membrane proteins, including CD14 
(3), CD16 (21), CD43 (4, 12, 46), CD44 (2, 12), and TNF 
receptor (32, 44), have been reported to be downmodulated 
upon leukocyte activation with PMA. Moreover, this mecha- 
nism is not limited to leukocytes, but rather appears to be 
involved in regulating cell surface expression of proteins on 
many cell types (15).  Proteins as diverse as the fl-amyloid 
precursor protein (41,  63),  the angiotensin-converting en- 
zyme  (14),  the  folate  receptor  (16),  growth  factor  and 
cytokine receptors,  such  as  TNF  receptor  (32,  44)  and 
CSF-1 receptor (13), as well as growth factors and cytokines 
themselves, such as TNF (33), TGF-cx (42), CSF-1 (57), and 
Kit ligand (22), have transmembrane forms that are cleaved 
to release soluble forms. 
A  protease involved in membrane proximal cleavage of 
cell surface proteins has not been identified in any system. 
Moreover, it is not clear whether these diverse transmem- 
brane proteins are cleaved by one common membrane prox- 
imal protease activity or multiple related or unrelated activi- 
ties. It is unusual that COS cells, which do not normally 
express L-selectin, can process L-selectin into fragments 
that are indistinguishable from those found with activated 
leukocytes. Transfection of COS or CHO cells with genes 
encoding transmembrane forms of TGF-o~ (43),  Kit ligand 
(22), TNF receptor (32), and ACE (14) also results in release 
of soluble proteins, suggesting the possibility of a common 
proteolytic pathway. However, the rapid kinetics of L-selec- 
tin shedding in response to a physiogical stimulus are un- 
usual. On neutrophil surfaces, CD43 and CD44 are down- 
regulated during a  15-60-rain period in response to PMA 
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Figure 6. Identification of the 
cleavage site by radiochemical 
sequencing. COS cells trans- 
fected  with  L-selectin  were 
metabolically  labeled  with 
[35S]methionine (A)  or  [3n]- 
phenylalanine (B), and PHA 
lymphoblasts  were  labeled 
with [35S]methionine and ac- 
tivated with  PMA  (C).  The 
6-kD  species was  immuno- 
precipitated  with  the  JK564 
anti-cytoplasmic  domain  se- 
rum, subjected to SDS-PAGE, 
and transferred  to PVDF mem- 
brane.  The  6-kD  band  was 
visualized  by  autoradiogra- 
phy, excised,  and  subjected 
to a pulse-liquid protein  se- 
quencer. Fractions from each 
cycle were collected and ana- 
lyzed. Assignment of methionine and phenylalanine residues were made based on radioactive peaks from [35S]methionine  and [3H]phenyl- 
alanine labeled cells, respectively, and aligned with the L-selectin sequence (D). 
(46), but this is in contrast to cleavage of L-selectin within 
5  rain.  Moreover,  PMA  is  an extremely potent and non- 
physiological activator of protein kinase  C,  that may ar- 
tificially accelerate the kinetics of downregulation of some 
proteins or may cause downregulation of  proteins that are not 
normally  shed.  Physiological  stimuli,  such  as  TNF  and 
fMLP, are very poor modulators of CD43 and CD44 cleav- 
age,  but cause efficient downregulation of L-selectin (4). 
Thus, it is unclear under what conditions CD43 and CD44 
would normally be rapidly downregulated. 
The mechanism involved to downmodulate L-selectin ex- 
pression is distinct from that of many other downregulated 
proteins in its sensitivity to protease inhibitors. As discussed 
above, L-selectin cleavage appears to be insensitive to a bat- 
tery  of common  protease  inhibitors.  In  marked  contrast 
common serine protease inhibitors have been shown to in- 
hibit release of pro-TGFo~  KL-1, CD14 and CD44 (3,  12, 
42), while metalloprotease inhibitors have been shown to in- 
hibit release of folate receptor and CD16-II (16, 21). Interest- 
ingly, downregulation of CD43  appears to be sensitive to 
both serine and metalloprotease inhibitors (4, 12, 46). These 
results suggest that the mechanism to downregulate L-selec- 
tin is distinct from the mechanism involved in downregula- 
tion of these other cell surface proteins, and they suggest at 
least three distinct protease activities: one susceptible to ser- 
ine protease inhibitors (3,  12,  42),  another susceptible to 
metalloprotease inhibitors (16, 21), and a third that is resis- 
tant to most common protease inhibitors (35,  44). 
Moreover, the cleavage sites for some of these proteins 
have been determined, but have no significant regions of ho- 
mology to  each other or to the putative cleavage site of 
L-selectin. The cleavage of TGF-a and Kit ligand has been 
mapped to a region rich in small apolar residues, such as ala- 
nine  and  valine  (42).  In  contrast,  the  cleavage region of 
L-selectin is strikingly devoid of these residues, and the ac- 
tual cleavage site (KtSFS) occurs after a charged lysine resi- 
due. It is possible that sequence specificity at the cleavage 
site is not necessary, but that positional effects or a protease 
docking  site  may be  more  critical  (7).  The Ser-Phe-Ser 
(SFS) motif after the cleavage site of L-selectin is conserved 
between human, mouse, and rat L-selectin (Fig. 5 B). In- 
terestingly, an SFS motif is found eight residues proximal to 
the transmembrane domain of CD16-II (45), and a related 
Ser-Phe-Leu motif is  found  18  residues  and  16  residues 
proximal to the transmembrane domains of TNF receptor 
type  II  (32)  and  ACE  (53),  respectively.  It  is  unknown 
whether these motifs are involved in the downregulation of 
these proteins, but it suggests the possibility of a common 
recognition sequence. 
Finally, we cannot formally exclude the possibility that the 
protease activity is intrinsic to L-selectin. There is precedent 
for autoproteolytic activity in proteins, although these pro- 
teins typically have conserved consensus sequences of one 
of the major protease families. L-selectin lacks any obvious 
homology to known proteases, although we cannot exclude 
the possibility of a novel or unusual protease. Letellier et al. 
(35) have provided evidence that the IgE Fc receptor, which 
like L-selectin has a  C-type lectin domain,  may have au- 
toproteolytic activity. 
The physiological requirement for rapid L-selectin down- 
regulation remains to be proven. It was originally postulated 
that L-selectin downregulation may be necessary for neutro- 
phils  to progress  from initial  contact to  transendothelial 
migration  (29).  Alternatively,  L-selectin  downregulation 
may serve as a protective mechanism to prevent neutrophils 
activated in circulation from entering an inappropriate tissue 
site. More recently, Palecanda et al. (40) showed that cross- 
linking of L-selectin causes its downregulation, and proposed 
that shedding of L-selectin may be a continuous process dur- 
ing neutrophil rolling and normal leukocyte trafficking.  The 
continuous release of L-selectin during leukocyte trafficking 
and neutrophil rolling in response to subclinical stimuli may 
account in part for the high levels of circulating L-selectin 
in normal serum (47). The finding that cultured neutrophils 
actively synthesized L-selectin suggests the possibility that 
at least some of the neutrophil L-selectin can be replenished 
by de novo synthesis. The identity of the natural cleavage site 
may be useful in designing sequence-specific protease inhib- 
The Journal of Cell Biology, Volume  125,  1994  468 itors to determine the biological consequences of interfering 
with this precisely regulated processing event and as a tool 
to identify the natural protease. 
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